Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-010837

Executive VP, Global R&D sold 1,841 shares at $17.67 ($32,529)

  • Executive VP, Global R&D acquired 5,353 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Fridriksdottir Hafrun · Executive VP, Global R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-14 Exercise or conversion : show line 1 in the form +5,353 17,178.51 D
2019-02-14 Sale : show line 2 in the form −1,841 $17.67 $32,529 15,337.51 D
Open-market sales · 1,841 sh · avg $17.67 · $32,529

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-14 Exercise or conversion : show line 3 in the form Restricted Share Units −5,353 10,708 D
Loading xslF345X03/doc4.xml…